Opinion: Health tech needs to rebuild trust in the wake of the Theranos verdict

Monday’s news that Elizabeth Holmes, the founder and CEO of Theranos, was found guilty of three counts of wire fraud and one count of conspiracy to defraud investors makes for sensational headlines.

But these headlines make it easy to lose sight of what is most important in this story and who was hurt: people reluctant to undergo diagnostic testing who could have benefited from Theranos’ purported innovations that would have lowered barriers to testing. They are now left with the status quo and have yet another reason to question the medical-innovation establishment that claims to want to help them.

Read the rest…